High muscle sympathetic nerve activity is associated with left ventricular dysfunction in treated hypertensive patients

American Journal of Hypertension

Volumn 26, Issue 7, 2013, Pages 912-917

  De Souza, Silvia Beatriz Cavasin ^a   Rocha, Juraci Aparecida ^a   Cuoco, Marco Antonio Romeu ^a   Guerra, Grazia Maria ^a   Ferreira Filho, Julio Cesar ^a   Borile, Suellen ^a   Krieger, Eduardo Moacyr ^a   Bortolotto, Luiz Aparecido ^a   Consolim Colombo, Fernanda Marciano ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

blood pressure; diastolic dysfunction; hypertension; muscle sympathetic nerve activity

Indexed keywords

AMLODIPINE; ENALAPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART RATE; HUMAN; HYPERTENSION; MALE; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRACTICE GUIDELINE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; HYPERTENSION; MUSCLE SYMPATHETIC NERVE ACTIVITY.;

ADULT; ANTIHYPERTENSIVE AGENTS; BAROREFLEX; BLOOD PRESSURE; DIASTOLE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLE, SKELETAL; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84878839685     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt032     Document Type: Article

References (38)

1. Redfield MM, Jacobsen SJ, Burnett JC Jr., Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
2. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003.
3. Fischer Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, Ding A, Broeckel U, Riegger G, Schunkert H. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24 320-328.
4. Abhayaratna WP, Marwick TH, Smith WT, Becker NG. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 2006;92:1259-1264.
5. Kuznetsova T, Herbots L, Lez B, Jin Y, Richart T, Thijs L, Gonzez A, Herregods MC, Fagard RH, Dz J, Staessen JA. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2009;2:105-112.
6. Fagard R, Pardaens K. Left ventricular diastolic function predicts outcome in uncomplicated hypertension. Am J Hypertens 2001;14: 504-508.
7. Achong N, Wahi S, Marwick TH. Evolution and outcome of diastolic dysfunction. Heart 2009;95:813-818.
8. Correa de Sa DD, Hodge DO, Slusser JP, Redfield MM, Simari RD, Burnett JC, Chen HH. Progression of preclinical diastolic dysfunction to the development of symptoms. Heart 2010;96:528-532.
9. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Arenare F, Spaziani D, Mancia G. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension 2009;53:205-209.
10. VI Brazilian Guidelines on Hypertension. Arq Bras Cardiol 2010;95:1-51.
11. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-491.
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463.
13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
14. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-193.
15. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 1979;59:919-957.
16. Task Force: Heart Rate Variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996;17:354-381.
17. Parlow J, Viale JP, Annat G, Hughson R, Quintin L. Spontaneous cardiac baroreflex in humans. Comparison with drug-induced responses. Hypertension 1995;25:1058-1068.
18. Noll G, Wenzel RR, de Marchi S, Shaw S, Lcher TF. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation 1997;95:2286-2292.
19. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997;96:1173-1179.
20. Grassi G, Turri C, Dell'Oro R, Stella ML, Bolla GB, Mancia G. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J Hypertens 1998;16:1789-1796.
21. Binggeli C, Corti R, Sudano I, Luscher TF, Noll G. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension. Hypertension 2002;39:892-896.
22. Grassi G, Seravalle G, Turri C, Bolla G, Mancia G. Short-versus longterm effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension 2003;41:558-562.
23. Wallin BG. Interindividual differences in muscle sympathetic nerve activity: a key to new insight into cardiovascular regulation Acta Physiol (Oxf) 2007;190:265-275.
24. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998;31:68-72.
25. Frattola A, Parati G, Cuspidi C, Albini F,Mancia G. Prognostic value of 24-h blood pressure variability. J Hypertens 1993;11:1133-1137.
26. Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 2006;24:1125-1135.
27. Saul JP, Rea RF, Eckberg DL, Berger RD, Cohen RJ. Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity. Am J Physiol 1990;25:H713-H721.
28. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994;90:234-240.
29. Notarius CF, Butler GC, Ando S, Pollard MJ, Senn BL, Floras JS. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure. Clin Sci (Lond) 1999;96:557-565.
30. Otto ME, Consolim-Colombo FM, Rodrigues Sobrinho CR, Krieger EM. Pressure and time dependence of the cardiovascular reflex response in patients with hypertensive cardiomyopathy. Braz J Med Biol Res 2004;37:1615-1622.
31. Giannattasio C, Seravalle G, Bolla G, Cattaneo BM, Cloux J, Cuspidi C, Sampieri L, Grassi G, Mancia G. Cardiac hypertrophy impairs cardiac receptor control of circulation in man. J Hypertens Suppl 1989;7:S56-S57.
32. Schillaci G, Pasqualini L, Verdecchia P, Vaudo G, Marchesi S, Porcellati C, De Simone G, Mannarino E. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 2002;39:2005-2011.
33. Munhoz RT, Negr CE, Barretto AC, Ochiai ME, Cardoso JN, Morgado PC, Del Carlo CH, Ramires JA. Microneurography and venous occlusion plethysmography in heart failure: correlation with prognosis. Arq Bras Cardiol 2009;92:46-53.
34. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565-570.
35. La Rovere MT. Autonomic markers of prognosis after myocardial infarction. Clin Sci (Lond) 1996;91:133-135.
36. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010;23:1052-1060.
37. Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-1535.
38. Boer-Martins L, Figueiredo VN, Demacq C, Martins LC, Consolin-Colombo F, Figueiredo MJ, Cannavan FP, Moreno H Jr. Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients. Cardiovasc Diabetol 2011;10:24.